Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Physiologic and pathologic abnormalities in severe asthma.

Sally Wenzel1

  • 1Department of Medicine, National Jewish Medical and Research Center, 1400 Jackson Street, Denver, CO 80206, USA. wenzels@njc.org

Clinics in Chest Medicine
|March 18, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to High IFN-γ and low SLPI mark severe asthma in mice and humans.

The Journal of clinical investigation·2025
Same author

Associations of Prepandemic Lung Function and Structure with COVID-19 Outcomes: The C4R Study.

American journal of respiratory and critical care medicine·2025
Same author

Severe asthma exacerbations associated with unconventional natural gas development activity in area of concentrated development.

The Journal of asthma : official journal of the Association for the Care of Asthma·2025
Same author

Serum cAMP levels are increased in patients with asthma.

The Journal of clinical investigation·2025
Same author

SARS-CoV-2 Accessory Protein Orf7b Induces Lung Injury via c-Myc Mediated Apoptosis and Ferroptosis.

International journal of molecular sciences·2024
Same author

IL-33 receptor inhibition in subjects with uncontrolled asthma: A randomized, placebo-controlled trial.

The journal of allergy and clinical immunology. Global·2023
Same journal

Pneumonia Reimagined: Host, Microbe, and the Shifting Landscape of Disease.

Clinics in chest medicine·2026
Same journal

Advocacy in Pneumonia.

Clinics in chest medicine·2026
Same journal

Vaccines Against Pneumonia: Current Updates.

Clinics in chest medicine·2026
Same journal

Non-antibiotic Treatments for Pneumonia: Host-Directed Therapies, Next-Steps and Future Directions.

Clinics in chest medicine·2026
Same journal

Customizing Antibiotic Treatment for Pneumonia: Can We Have a Single Unified Algorithm for All Types of Pneumonia?

Clinics in chest medicine·2026
Same journal

The Role of Complex Digital Interventions to Improve Pneumonia Care.

Clinics in chest medicine·2026
See all related articles

Severe asthma is a complex, heterogeneous disease. Understanding its distinct phenotypes, like early- versus late-onset, is key to improving treatment responses and patient outcomes.

Area of Science:

  • Pulmonology
  • Immunology
  • Allergy

Background:

  • Severe asthma is a heterogeneous condition, making it difficult to understand and treat effectively.
  • Recent advancements have improved the characterization of severe asthma phenotypes and associated abnormalities.
  • Distinguishing between early- and late-onset severe asthma reveals different underlying mechanisms.

Purpose of the Study:

  • To delineate the characteristics of different severe asthma phenotypes.
  • To investigate the role of allergy and eosinophilia in early- and late-onset severe asthma.
  • To explore the potential for phenotype-specific treatment responses in severe asthma.

Main Methods:

  • Phenotypic analysis of severe asthma patients.
  • Assessment of allergic markers and eosinophil counts.

Related Experiment Videos

  • Correlation of clinical presentation with disease onset and severity.

    • Main Results:

    • Early-onset severe asthma shows a stronger association with allergies.
    • Persistent eosinophilia is more prevalent in late-onset disease and linked to higher symptom burden in both types.
    • Treatment response in severe asthma may be influenced by the identified phenotype.

    Conclusions:

    • Severe asthma heterogeneity necessitates a phenotype-based approach for better management.
    • Allergy and eosinophil levels are important biomarkers for classifying severe asthma.
    • Tailoring therapies to specific severe asthma phenotypes holds promise for improved treatment efficacy.